Virtual screening of GPCRs: an in silico chemogenomics approach.
BACKGROUND
The G-protein coupled receptor (GPCR) superfamily is currently the largest class of therapeutic targets. In silico prediction of interactions between GPCRs and small molecules in the transmembrane ligand-binding site is therefore a crucial step in the drug discovery process, which remains a daunting task due to the difficulty to characterize the 3D structure of most GPCRs, and to the limited amount of known ligands for some members of the superfamily. Chemogenomics, which attempts to characterize interactions between all members of a target class and all small molecules simultaneously, has recently been proposed as an interesting alternative to traditional docking or ligand-based virtual screening strategies.


RESULTS
We show that interaction prediction in the chemogenomics framework outperforms state-of-the-art individual ligand-based methods in accuracy both for receptor with known ligands and without known ligands. This is done with no knowledge of the receptor 3D structure. In particular we are able to predict ligands of orphan GPCRs with an estimated accuracy of 78.1%.


CONCLUSIONS
We propose new methods for in silico chemogenomics and validate them on the virtual screening of GPCRs. The methods represent an extension of a recently proposed machine learning strategy, based on support vector machines (SVM), which provides a flexible framework to incorporate various information sources on the biological space of targets and on the chemical space of small molecules. We investigate the use of 2D and 3D descriptors for small molecules, and test a variety of descriptors for GPCRs. We show that incorporating information about the known hierarchical classification of the target family and about key residues in their inferred binding pockets significantly improves the prediction accuracy of our model.
Jacob
Laurent
L
Mines ParisTech, Centre for Computational Biology, 35 rue Saint-Honoré, F-77305, Fontainebleau, France. laurent.jacob@mines-paristech.fr
Hoffmann
Brice
B
Stoven
Véronique
V
Vert
Jean-Philippe
JP
D001665:Binding Sites; D003198:Computer Simulation; D016503:Drug Delivery Systems / Q000379:methods*; D008956:Models, Chemical; D008958:Models, Molecular; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D011485:Protein Binding; D025941:Protein Interaction Mapping / Q000379:methods*; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000648:ultrastructure*
D004364:Pharmaceutical Preparations; D043562:Receptors, G-Protein-Coupled
Nat Biotechnol. 2008 Feb;26(2):189-91
18259173
Neural Netw. 2005 Oct;18(8):1093-110
16157471
Science. 2007 Nov 23;318(5854):1258-65
17962520
Neural Netw. 2005 Oct;18(8):1111-23
16198086
Bioinformatics. 2005 Jun;21 Suppl 1:i47-56
15961493
Cell Signal. 2006 Dec;18(12):2105-20
16828259
Bioinformatics. 2001 May;17(5):455-60
11331240
Toxicol Pathol. 1995 Mar-Apr;23(2):102-14
7569663
Acta Physiol (Oxf). 2007 May;190(1):3-7
17428227
J Med Chem. 2008 Feb 14;51(3):581-8
18198821
BMC Bioinformatics. 2005 Mar 10;6:50
15760465
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10915-9
1438297
Ann Med. 2004;36(3):204-14
15181976
Proteins. 2006 Feb 1;62(2):509-38
16294340
J Chem Inf Model. 2005 Sep-Oct;45(5):1402-14
16180917
J Comput Biol. 2000 Feb-Apr;7(1-2):95-114
10890390
Bioinformatics. 2004 Mar 1;20(4):467-76
14990442
J Mol Graph Model. 2003 Mar;21(5):449-62
12543140
J Chem Inf Model. 2007 May-Jun;47(3):965-74
17338509
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
Pac Symp Biocomput. 2002;:564-75
11928508
J Med Chem. 2002 Jun 6;45(12):2615-23
12036371
Bioorg Med Chem Lett. 2005 Aug 15;15(16):3707-12
15993056
J Bioinform Comput Biol. 2005 Jun;3(3):527-50
16108083
Br J Pharmacol. 2007 Sep;152(1):5-7
17533415
Proteins. 1996 Sep;26(1):81-94
8880932
Proteins. 2004 Oct 1;57(1):51-86
15326594
Nucleic Acids Res. 2003 Jul 1;31(13):3497-500
12824352
Br J Pharmacol. 2007 Sep;152(1):38-52
17533416
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11304-9
15277683
Br J Pharmacol. 2006 Jan;147 Suppl 1:S27-37
16402114
J Chem Inf Comput Sci. 2002 Nov-Dec;42(6):1332-42
12444729
Bioinformatics. 2002;18 Suppl 1:S276-84
12169557
J Mol Biol. 2005 Jan 7;345(1):187-99
15567421
Proteins. 2003 Jan 1;50(1):5-25
12471595
J Chem Inf Model. 2005 Sep-Oct;45(5):1324-36
16180909
Nucleic Acids Res. 2003 Jan 1;31(1):294-7
12520006
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
11259830
J Med Chem. 2005 Feb 24;48(4):1088-97
15715476
Bioinformatics. 2007 May 1;23(9):1090-8
17234638
Bioinformatics. 2008 Oct 1;24(19):2149-56
18676415
Curr Top Med Chem. 2007;7(10):991-8
17508932
J Mol Biol. 2004 Sep 10;342(2):571-83
15327956
J Chem Inf Model. 2006 Sep-Oct;46(5):2003-14
16995731
Biochemistry. 2003 Mar 18;42(10):2759-67
12627940
EMBO J. 1999 Apr 1;18(7):1723-9
10202136
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):391-405
12653501
J Chem Inf Model. 2005 Jul-Aug;45(4):939-51
16045288
J Med Chem. 2005 Oct 20;48(21):6563-74
16220973
Nat Rev Drug Discov. 2002 Sep;1(9):727-30
12209152
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D673-7
16381956
Proteins. 1992 Oct;14(2):309-23
1409577
Bioinformatics. 2005 Dec 1;21(23):4289-96
16204343
Bioinformatics. 2008 Feb 1;24(3):358-66
18083718
Biochim Biophys Acta. 2007 Apr;1768(4):794-807
17188232
J Chem Inf Model. 2007 Jul-Aug;47(4):1626-37
17580929
Bioinformatics. 2004 Jul 22;20(11):1682-9
14988126
Proteins. 2003 May 15;51(3):423-33
12696053
J Chem Inf Model. 2006 Mar-Apr;46(2):626-35
16562992
J Biol Chem. 2007 Aug 31;282(35):25677-86
17591774
Biochim Biophys Acta. 2007 Apr;1768(4):976-93
17078926
J Med Chem. 2005 May 5;48(9):3164-70
15857122
Nat Chem Biol. 2006 Aug;2(8):417-22
16799554
J Chem Inf Comput Sci. 2002 Jul-Aug;42(4):947-55
12132896
J Med Chem. 2000 Oct 19;43(21):3867-77
11052792
Bioinformatics. 2002;18 Suppl 1:S268-75
12169556